<DOC>
	<DOCNO>NCT00892892</DOCNO>
	<brief_summary>The primary purpose assess role sympathetic activation development progression chronic renal failure . Using microneurography sympathetic activity register various stage kidney affection failure hypertension . A sympatholytic agent compare non-sympatholytic drug ass effect sympathetic activation progression kidney disease . The effect sympatholytic agent cardiovascular reactivity various stressor wil examine .</brief_summary>
	<brief_title>Sympathetic Nerve Activity Renal Failure</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Rilmenidine</mesh_term>
	<mesh_term>Nitrendipine</mesh_term>
	<mesh_term>Sympatholytics</mesh_term>
	<criteria>chronic renal failure stage IIV pregnancy lactation severe heart failure ischemic heart disease patient NYHA IIIIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>sympatholytic treatment</keyword>
	<keyword>sympathetic nerve activity</keyword>
</DOC>